Infections after allogeneic hematopoietic stem cell transplantation with a nonmyeloablative conditioning regimen

Defining Opportunistic Invasive Fungal Infections in Immunocompromised Patients with Cancer and Hematopoietic Stem Cell Transplants: An International Consensus

2002 • 2,342 citations

Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects

2001 • 1,420 citations

Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors

2002 • 949 citations

1997 Guidelines for the Use of Antimicrobial Agents in Neutropenic Patients with Unexplained Fever

1997 • 671 citations

Late cytomegalovirus disease and mortality in recipients of allogeneic hematopoietic stem cell transplants: importance of viral load and T-cell immunity

2002 • 602 citations

Engraftment Kinetics After Nonmyeloablative Allogeneic Peripheral Blood Stem Cell Transplantation: Full Donor T-Cell Chimerism Precedes Alloimmune Responses

1999 • 547 citations

Risks and outcomes of invasive fungal infections in recipients of allogeneic hematopoietic stem cell transplants after nonmyeloablative conditioning

2003 • 471 citations

Low-dose total body irradiation (TBI) and fludarabine followed by hematopoietic cell transplantation (HCT) from HLA-matched or mismatched unrelated donors and postgrafting immunosuppression with cyclosporine and mycophenolate mofetil (MMF) can induce durable complete chimerism and sustained remissions in patients with hematological diseases

2003 • 469 citations

High incidence of cytomegalovirus infection after nonmyeloablative stem cell transplantation: potential role of Campath-1H in delaying immune reconstitution

2002 • 367 citations

Morbidity and mortality with nonmyeloablative compared with myeloablative conditioning before hematopoietic cell transplantation from HLA-matched related donors

2004 • 324 citations

Incidence and outcome of bacterial and fungal infections following nonmyeloablative compared with myeloablative allogeneic hematopoietic stem cell transplantation: A matched control study

2002 • 258 citations

Incidence and outcome of cytomegalovirus infections following nonmyeloablative compared with myeloablative allogeneic stem cell transplantation, a matched control study

2002 • 247 citations

Invasive fungal infections after allogeneic peripheral blood stem cell transplantation: incidence and risk factors in 395 patients

2002 • 218 citations

Mixed chimerism: Preclinical studies and clinical applications

1999 • 188 citations

Longitudinal Study of Bacterial, Viral, and Fungal Infections in Adult Recipients of Bone Marrow Transplants

2001 • 136 citations

High rate of secondary viral and bacterial infections in patients undergoing allogeneic bone marrow mini-transplantation

2000 • 120 citations

Allogeneic hematopoietic stem cell transplantation—Yesterday, today, and tomorrow

2003 • 108 citations

Immunologic recovery after hematopoietic cell transplantation with nonmyeloablative conditioning

2003 • 101 citations

High Rate of Invasive Fungal Infections Following Nonmyeloablative Allogeneic Transplantation

2003 • 99 citations

Reduced-intensity conditioning reduces the risk of severe infections after allogeneic peripheral blood stem cell transplantation

2001 • 79 citations

Nonmyeloablative Hematopoietic Cell Transplantation

2001 • 77 citations

Nonmyeloablative bone marrow transplantation: infectious complications in 65 recipients of HLA-identical and mismatched transplants

2003 • 61 citations

Unique risk factors for bacteraemia in allogeneic bone marrow transplant recipients before and after engraftment

1998 • 56 citations

Increased risk of complicated CMV infection with the use of mycophenolate mofetil in allogeneic stem cell transplantation

2002 • 51 citations

Bacteremia after hematopoietic stem cell transplantation: incidence and predictive value of surveillance cultures

2004 • 47 citations

Nonmyeloablative stem cell transplantation: reduced-intensity conditioning for cancer immunotherapy—from bench to patient bedside

2004 • 38 citations

Infectious complications within the first year after nonmyeloablative allogeneic peripheral blood stem cell transplantation

2001 • 35 citations

Cytomegalovirus infections in allogeneic stem cell recipients after reduced-intensity or myeloablative conditioning assessed by quantitative PCR and pp65-antigenemia

2003 • 33 citations

Nonmyeloablative Allogeneic Hematopoietic Stem Cell Transplantation

2002 • 33 citations

High-dose acyclovir and pre-emptive ganciclovir to prevent cytomegalovirus disease in myeloablative and non-myeloablative allogeneic stem cell transplantation

2002 • 30 citations

T-cell reconstitution after unmanipulated, CD8-depleted or CD34-selected nonmyeloablative peripheral blood stem-cell transplantation

2003 • 28 citations

Nonmyeloablative Stem Cell Transplantation with CD8-Depleted or CD34-Selected Peripheral Blood Stem Cells

2002 • 23 citations

Changing pattern of bacterial susceptibility to antibiotics in hematopoietic stem cell transplant recipients

2002 • 21 citations

Development of early neutropenic fever, with or without bacterial infection, is still a significant complication after reduced-intensity stem cell transplantation

2004 • 19 citations

Definitions of infectious diseases and complications after stem cell transplant

2002 • 8 citations

Cited By (0)

Loading...